Results 191 to 200 of about 617,669 (345)

High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas

, 1988
Barry M. Kacinski, Darryl Carter, Khushbakhat Mittal, Ernest I. Kohorn, Ralph Bloodgood, John K. Donahue, Lisa Donofrio, Rob Edwards, Peter E. Schwartz, Joseph T. Chambers, Setsuko K. Chambers   +10 more
openalex   +1 more source

The Search for Oncogene Targets [PDF]

, 1989
E. Racker
openalex   +1 more source

An Engineered Soluble Single‐Chain TCR Engager for KRAS‐G12V Specific Tumor Immunotherapy

Advanced Science, EarlyView.
This study develops a dimeric T cell receptor engager protein specific for tumor KRAS‐G12V mutation. The engager proteins are capable of mediating the formation of synapse between T cell and tumor cell and demonstrate substantial tumor suppression efficacy.
Keke Ma, Jie Wang, Min Jiang, Juanhua He, Fangyang Li, Dan Lu, Chao Su, Yan Chai, Wenjing Jin, Yu Chen, Catherine W.H. Zhang, Xiaopeng Ma, Hui Tan, George F. Gao, Shuguang Tan   +14 more
wiley   +1 more source

Effects of two major activating lesions on the structure and conformation of human ras oncogene products.

, 1985
S. K. Srivastava, Yasuhito Yuasa, Steven H. Reynolds, Stuart A. Aaronson   +3 more
openalex   +1 more source

MYC/TET3‐Regulated TMEM65 Activates OXPHOS‐SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
Triple‐negative breast cancer (TNBC) remains a major challenge in breast cancer management as it lacks effective therapeutic targets. This study uncovers that MYC/TET3‐regulated mitochondrial inner‐membrane protein TMEM65 promotes TNBC progression and cisplatin resistance by activating the OXPHOS‐SERPINB3 pathway and reveals TMEM65 as a potential ...
Yin‐Ling Zhang, Min‐Ying Huang, Shao‐Ying Yang, Jia‐Yang Cai, Qian Zhao, Fang‐Lin Zhang, Xin Hu, Zhi‐Min Shao, Li Liao, A‐Yong Cao, Da‐Qiang Li   +10 more
wiley   +1 more source

Tyrosine phosphorylation and oncogenes [PDF]

, 1981
Peter Newmark
openalex   +1 more source

PTf‐SRiApt Targeting SCAF4‐POLR2A Interaction Suppresses Tumor Growth and Promotes Antitumor Immunity in Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
A phosphorothioate‐modified aptamer PTf‐SRiApt capable of disrupting “undruggable” transcription factor SCAF4‐POLR2A interaction with high inhibitory activity and biological stability is presented here. Through this inhibition, PTf‐SRiApt successfully arrested cell cycle progression, induced cell death, and elevated immune recruitment in SCAF4‐POLR2A ...
Liyan Fei, Yichun Pan, Jie Zhai, Tongqing Li, Yuxin Zhou, Sheyu Zhang, Juan Wei, Qian Hu, Xueying Liu, Lu Guo, Weizhu Wu, Yong Wei, Qin Wu, Weihong Tan   +13 more
wiley   +1 more source

Generation of a spontaneous murine HPV + oral cancer model with site-specific oncogene insertion using CRISPR-SONIC. [PDF]

Cell Biosci
Tao J, Murray J, Tu HF, Fan D, Tsai YC, Hu MH, Wu AA, Xing D, Hung CF, Wu TC.   +9 more
europepmc   +1 more source

Editorial Expression of Concern: Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma

Molecular Cancer
Satyabrata Sinha, Ratnesh K. Singh, Neyaz Alam, Anup Roy, Susanta Roychoudhury, Chinmay Kumar Panda   +5 more
doaj   +1 more source

Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.

, 1989
Peter J. Hurlin, Vincent Maher, J. Justin McCormick   +2 more
openalex   +1 more source